3rd Quarter - Report

ADAPTIVE BIOTECHNOLOGIES for ADAPTIVE BIOTECHNOLOGIES

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to T-cells, COVID testing, and immune medicine

LobbyistCovered position, as disclosed
PAMELA LYNN BRADLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to T cells, COVID testing, and immune medicine. H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions

LobbyistCovered position, as disclosed
PAMELA LYNN BRADLEY covered legislative branch official

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6102 (117th), S. 3404 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.